American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Lyra Therapeutics, Inc. (LYRA)

$0.19 +0.00% OTC: LYRA · 15-min delayed

WATERTOWN, Massachusetts
Public · OTC: LYRA

Visit website Follow

$398.0KRevenue · FY2025

-$28.9MNet income

LYRAOTC

About Lyra Therapeutics, Inc.

LYRA THERAPEUTICS INC

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · OTC: LYRA
Headquarters: WATERTOWN, Massachusetts
Industry: Medical Devices
Website: Visit site

Registry IDs

Ticker: LYRA OTC
SEC CIK: 1327273
SIC: 3841 Surgical & Medical Instruments & Apparatus

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Lyra Therapeutics, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/lyra-therapeutics-inc/"><img src="https://americancompanies.com/badge/lyra-therapeutics-inc.svg" alt="Lyra Therapeutics, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow Lyra Therapeutics, Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $398.0K
Net income: -$28.9M
Total assets: $36.1M

Source: SEC EDGAR · updated Jun 8, 2026

OTC: LYRA

$0.19 +0.00%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.00 $8.09

52-week range

Open: —
Day range: –
Prev close: —
Volume: —

Lyra Therapeutics, Inc. (LYRA) Stock Price

Reported a net loss of $28.9M in FY2025.
Trading 98% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Lyra Therapeutics, Inc..

Write a review

Newsroom

News about Lyra Therapeutics, Inc.

Lyra Therapeutics Reports Positive Results from the ENLIGHTEN 2 Phase 3 Trial of LYR-210 Achieving Statistically Significant Results for Primary and Key Secondary Endpoints in the Treatment of Chronic Rhinosinusitis (CRS) GlobeNewswire Inc. · 2025-06-02 · positive Lyra Therapeutics to Present 52-week Extension Stage Results for ENLIGHTEN 1 Phase 3 Study for LYR-210 for the Treatment of Chronic Rhinosinusitis at COSM 2025 GlobeNewswire Inc. · 2025-05-07 · positive Lyra Therapeutics Fully Enrolls Pivotal Phase 3 ENLIGHTEN 2 Trial of LYR-210 for the Treatment of Chronic Rhinosinusitis GlobeNewswire Inc. · 2024-10-15 · positive Lyra Therapeutics to Present Study Results for LYR-210 and LYR-220 in Two Presentations at the ARS and AAO-HNS Annual Meetings GlobeNewswire Inc. · 2024-09-27 · positive Lyra Therapeutics Announces Cost-Cutting Measures to Preserve Capital GlobeNewswire Inc. · 2024-05-21 Where Lyra Therapeutics Stands With Analysts Benzinga · 2024-05-07

News & sentiment via Polygon.io

FAQ

Lyra Therapeutics, Inc.: frequently asked questions

Is Lyra Therapeutics, Inc. an American company?

Lyra Therapeutics, Inc. is a US-based company headquartered in Watertown, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Lyra Therapeutics, Inc. headquartered?

Lyra Therapeutics, Inc. is headquartered in Watertown, Massachusetts, United States.

Is Lyra Therapeutics, Inc. publicly traded?

Yes — Lyra Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol LYRA on the OTC.

What does Lyra Therapeutics, Inc. do?

Lyra Therapeutics, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore